98%
921
2 minutes
20
Supercapacitors (SCs) have attracted attention as an important energy source for various applications owing to their high power outputs and outstanding energy densities. The electrochemical performance of an SC device is predominantly determined by electrode materials, and thus, the selection and synthesis of the materials are crucial. Metal oxides (MOs) and their composites are the most widely used pseudocapacitive SC electrode materials. The basic requirements for fabricating high-performance SC electrodes include synthesizing and/or chemically modifying unique conducting nanostructures, optimizing a heterostructure morphology, and generating large-surface-area electroactive sites, all of which predominantly rely on various techniques used for synthesizing MO materials and fabricating MO- and MO-composite-based SC electrodes. Therefore, an SC's background and critical aspects, the challenges associated with the predominant synthesis techniques (including hydrothermal and microwave-assisted syntheses and chemical-bath and atomic-layer depositions), and resulting electrode electrochemical performances should be summarized in a convenient, accessible report to accelerate the development of materials for industrial SC applications. Therefore, we reviewed the most pertinent studies on these synthesis techniques to provide insight into the most recent advances in synthesizing MOs and fabricating their composite-based SC electrodes as well as to propose research directions for developing MO-based electrodes for applications to next-generation SCs.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9181971 | PMC |
http://dx.doi.org/10.3390/nano12111873 | DOI Listing |
N Engl J Med
September 2025
Rwanda Biomedical Center, Kigali.
Background: On September 27, 2024, Rwanda reported an outbreak of Marburg virus disease (MVD), after a cluster of cases of viral hemorrhagic fever was detected at two urban hospitals.
Methods: We report key aspects of the epidemiology, clinical manifestations, and treatment of MVD during this outbreak, as well as the overall response to the outbreak. We performed a retrospective epidemiologic and clinical analysis of data compiled across all pillars of the outbreak response and a case-series analysis to characterize clinical features, disease progression, and outcomes among patients who received supportive care and investigational therapeutic agents.
Arq Bras Cardiol
September 2025
Instituto do Coração do Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, São Paulo, SP - Brasil.
Targeted temperature management (TTM) is currently the only potentially neuroprotective intervention recommended for post-cardiac arrest care. However, there are concerns among the scientific community regarding conflicting evidence supporting this recommendation. Moreover, the bulk of trials included in systematic reviews that inform guidelines and recommendations have been conducted in developed countries, with case mix and patient characteristics that significantly differ from the reality of developing countries such as Brazil.
View Article and Find Full Text PDFHigh Alt Med Biol
September 2025
Division of Pulmonary, Critical Care and Sleep Medicine, Department of Medicine, University of Washington, Seattle, Washington, USA.
Manferdelli, Giorgio, Marc M Berger, and Andrew M Luks.Ignoble Gas: The Questionable Role of Xenon in Rapid Ascents of Mount Everest. 00:00-00, 2025.
View Article and Find Full Text PDFHealth Expect
October 2025
JC School of Public Health and Primary Care, The Chinese University of Hong Kong, Hong Kong, China.
Objective: This study examined the content validity of EQ-5D for Chinese patients with DMD. Specifically, it investigated: (1) the content validity of EQ-5D-5L in adult DMD patients and (2) the content validity of EQ-5D-Y-3L (Y-3L) in DMD patients aged 8-15 years.
Method: This qualitative study used semi-structured interviews and conducted one-on-one and online, with two groups of individuals with DMD to examine the content validity of the EQ-5D-5L and Y-3L.
Proc Natl Acad Sci U S A
September 2025
Department of Biology, Massachusetts Institute of Technology, Cambridge, MA 02139.
The mutagenic translesion synthesis (TLS) pathway, which is critically dependent on REV1's ability to recruit inserter TLS polymerases and the POLζ extender polymerase, enables cancer cells to bypass DNA lesions while introducing mutations that likely contribute to the development of chemotherapy resistance and secondary malignancies. Targeting this pathway represents a promising therapeutic strategy. Here, we demonstrate that the expression of the C-terminal domain (CTD) of human REV1, a ca.
View Article and Find Full Text PDF